Search

Search Constraints

You searched for: Author/Creator Landsburg, Daniel J.

Search Results

2. A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma. Issue 1 (2nd January 2023)

4. Autologous stem cell transplantation in first complete remission may not extend progression‐free survival in patients with peripheral T cell lymphomas. Issue 7 (24th April 2016)

6. Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B‐cell lymphoma. Issue 3 (24th December 2019)

7. Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses. (2nd August 2021)

8. Front‐line, dose‐escalated immunochemotherapy is associated with a significant progression‐free survival advantage in patients with double‐hit lymphomas: a systematic review and meta‐analysis. (24th April 2015)

9. Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma. Issue 4 (13th November 2015)